The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC

Abstract Several observational studies suggested that gut microbiome-affecting-medication impairs the effectiveness of immunotherapy in patients with metastatic non-small-cell lung cancer (NSCLC). We postulated that if the effectiveness of immunotherapy is affected by drug-related changes of the mic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: M. V. Verschueren, C. M. Cramer - van der Welle, M. Tonn, F. M. N. H. Schramel, B. J. M. Peters, E. M. W. van de Garde
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a0e194b7608d42b8959e5d8b5ea66396
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!